Skip to main content
NIH funding notice RFA-CA-22-040

The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)

Closed on September 8, 2022.

Posted
July 18, 2022
Close date
September 8, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,175,478 in first-year total cost, median $703,424.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 SRB-P (J2)]3

Most frequent institutions

  1. FRED HUTCHINSON CANCER CENTER1
  2. JOHNS HOPKINS UNIVERSITY1
  3. NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
Competing awards under RFA-CA-22-040 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment1U2CCA271873-01A1HOOFNAGLE, ANDREW NPAULOVICH, AMANDA GWANG, PEIFRED HUTCHINSON CANCER CENTER, WA$792,490ZCA1
2023Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer1U2CCA271890-01A1PASS, HARVEY IRASEGAL, LEOPOLDO NICOLASNEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY$703,424ZCA1
2023BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs1U2CCA271895-01A1CHAN, DANIEL WANYUIZHANG, HUIJOHNS HOPKINS UNIVERSITY, MD$679,564ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-CA-22-040: The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) | ScienceDex | ConductScience